End-of-day quote
Other stock markets
|
||
- USD | - |
Chart calendar RXi Pharmaceuticals Corp
Upcoming events on RXi Pharmaceuticals Corp
Past events on RXi Pharmaceuticals Corp
05/07/2024 | Reverse Split: 1 of 9 |
17/06/2024 06:30 pm | Annual General Meeting |
17/05/2024 03:00 am | Society for Investigative Dermatology Meeting - Abstract No: 283 |
17/05/2024 03:00 am | Society for Investigative Dermatology Meeting - Abstract No: 576 |
17/05/2024 03:00 am | Society for Investigative Dermatology Meeting - Abstract No: 575 |
10/05/2024 02:55 am | Q1 2024 Earnings Release |
08/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract Number:774 |
02/04/2024 05:00 pm | Q4 2023 Earnings Release |
22/03/2024 10:30 pm | Immunotherapy of Cancer Conference |
21/03/2024 10:30 pm | Immunotherapy of Cancer Conference |
21/03/2024 10:30 pm | Immunotherapy of Cancer Conference - Poster No : P01.03 |
10/11/2023 03:00 am | Q3 2023 Earnings Release |
04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
14/10/2023 10:00 pm | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
14/10/2023 10:00 pm | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
11/08/2023 02:00 am | Q2 2023 Earnings Release |
20/07/2023 06:30 pm | Annual General Meeting |
18/05/2023 12:30 am | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
12/05/2023 02:30 am | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -10,8 -12,0 9.8% | -9,60 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
Net income Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
EPS USD | Released Forecast Spread | -2 088 -2 020 -3.37% | -207 -207 0% | -112 -120 6.31% | -90,9 -98,3 7.51% | -46,8 -56,3 16.93% | -16,4 |
Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
EBIT Million USD | Released Forecast Spread | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -1,90 -3,10 38.74% | -2,30 | -2,50 | -2,60 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,30 | -2,50 | -2,60 | ||
Net income Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,15 | -2,30 | -2,50 | -2,60 |
EPS USD | Released Forecast Spread | -20,5 -32,4 36.67% | -20,5 -33,5 38.71% | -28,1 38,9 -172.22% | -21,8 -29,2 25.31% | -13,2 | -10,3 -12,9 20.28% | -1,53 -11,7 86.92% | -4,23 | -4,59 | -4,14 | -3,60 |
Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 | 09/05/24 | - | - | - |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
22/07/2024 04:30 pm | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
29/07/2024 | CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected) |
Past sector events for RXi Pharmaceuticals Corp
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
10/07/2024 12:31 pm | SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release |
10/07/2024 11:21 am | POLARIS GROUP: June 2024 Sales and Revenue Release |
11/06/2024 12:34 pm | SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release |
07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
- Stock Market
- Equities
- PHIO Stock
- Stock
- Calendar RXi Pharmaceuticals Corp